The Latest in Multiple Sclerosis

Clinical Neurology News

MS cognitive decline buffered by early high vitamin D levels

October 13, 2018

Multiple Sclerosis

Clinical Neurology News

Novel IL-6 antibody slashes relapse rates in neuromyelitis optica

October 13, 2018

Multiple Sclerosis

Clinical Neurology News

Nf-L levels predictive of brain atrophy, disability in progressive MS

October 13, 2018

Multiple Sclerosis

Clinical Neurology News

Low spinal cord volume linked to higher MS disability

October 12, 2018

Multiple Sclerosis

Clinical Neurology News

Oligoclonal bands, initial seizures increase risk of post-ADEM epilepsy in children

October 12, 2018

Neurology Reviews

Do Dimethyl Fumarate and Teriflunomide Have Equivalent Efficacy?

October 12, 2018

Multiple Sclerosis

Neurology Reviews

Cortical Damage at Onset May Indicate Risk of Secondary Progressive MS

October 12, 2018

Multiple Sclerosis

Neurology Reviews

When Is the Optimal Time to Start Treatment in Patients With Relapsing-Remitting MS?

October 12, 2018

Multiple Sclerosis

Clinical Neurology News

Relapsing-remitting MS best treated within 6 months of onset

October 12, 2018

Multiple Sclerosis

Neurology Reviews

Level of Serum Neurofilament Light Enables Treatment Monitoring

October 11, 2018

Multiple Sclerosis

Clinical Neurology News

Mood disorders worsen multiple sclerosis disability

October 11, 2018

Multiple Sclerosis

Clinical Neurology News

Revamped MS criteria boost pediatric diagnoses

October 11, 2018

Clinical Neurology News

No elevated cancer risk with MS therapies in COMBAT-MS data

October 11, 2018

Multiple Sclerosis

Clinical Neurology News

Virus-specific T-cell infusion may resolve progressive multifocal leukoencephalopathy

October 10, 2018

Clinical Neurology News

Studies reveal pregnancy trends in American women with MS

October 5, 2018

Multiple Sclerosis